OBJECTIVES: To assess aggressive medical care, hospice utilization, and advance care documentation among ovarian cancer patients in the final thirty days of life. METHODS: Ovarian, fallopian tube, or primary peritoneal cancer patients registered at our institution during 2007-2011 were identified. Statistical analyses included Wilcoxon-Mann-Whitney, Chi-square analysis, and multivariate analysis. RESULTS: 183 patients met inclusion criteria. Median age at diagnosis was 58. Most were white and had advanced ovarian cancer. Fifty percent had experienced at least one form of aggressive care during the last 30days of life. Patients with provider recommendations to enroll in hospice were more likely to do so (OR 27.7, p=<0.001), with a median hospice stay of 18days before death. Seventy-five percent had an in-hospital DNR order and 33% had an out-of-hospital DNR order. These orders were created a median of 15 and 12days prior to death, respectively. Twenty-eight percent had a Medical Power of Attorney and 20% had a Living Will. These documents were created a median of 381 and 378days prior to death, respectively. CONCLUSIONS: Many ovarian cancer patients underwent some form of aggressive medical care in the last 30days of life. The time between hospice enrollment and death was short. Patients created Medical Power of Attorney and Living Will documents far in advance of death. DNR orders were initiated close to death.
OBJECTIVES: To assess aggressive medical care, hospice utilization, and advance care documentation among ovarian cancerpatients in the final thirty days of life. METHODS:Ovarian, fallopian tube, or primary peritoneal cancerpatients registered at our institution during 2007-2011 were identified. Statistical analyses included Wilcoxon-Mann-Whitney, Chi-square analysis, and multivariate analysis. RESULTS: 183 patients met inclusion criteria. Median age at diagnosis was 58. Most were white and had advanced ovarian cancer. Fifty percent had experienced at least one form of aggressive care during the last 30days of life. Patients with provider recommendations to enroll in hospice were more likely to do so (OR 27.7, p=<0.001), with a median hospice stay of 18days before death. Seventy-five percent had an in-hospital DNR order and 33% had an out-of-hospital DNR order. These orders were created a median of 15 and 12days prior to death, respectively. Twenty-eight percent had a Medical Power of Attorney and 20% had a Living Will. These documents were created a median of 381 and 378days prior to death, respectively. CONCLUSIONS: Many ovarian cancerpatients underwent some form of aggressive medical care in the last 30days of life. The time between hospice enrollment and death was short. Patients created Medical Power of Attorney and Living Will documents far in advance of death. DNR orders were initiated close to death.
Authors: Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Erin A Keyser; Beverly G Reed; William J Lowery; Michael J Sundborg; William E Winter; John A Ward; Charles A Leath Journal: Gynecol Oncol Date: 2010-06-12 Impact factor: 5.482
Authors: Kathleen M Fairfield; Kimberly M Murray; Heidi R Wierman; Paul K J Han; Sarah Hallen; Susan Miesfeldt; Edward L Trimble; Joan L Warren; Craig C Earle Journal: Gynecol Oncol Date: 2011-12-01 Impact factor: 5.482
Authors: Jonathan Bergman; Christopher S Saigal; Karl A Lorenz; Janet Hanley; David C Miller; John L Gore; Mark S Litwin Journal: Arch Intern Med Date: 2010-10-11
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Jolyn S Taylor; Suja S Rajan; Ning Zhang; Larissa A Meyer; Lois M Ramondetta; Diane C Bodurka; David R Lairson; Sharon H Giordano Journal: J Clin Oncol Date: 2017-04-07 Impact factor: 44.544
Authors: Vivian E von Gruenigen; Helen Q Huang; David Cella; MichaelA Zevon; Jason A LaChance; Joan L Walker; Ritu Salani; Susan C Modesitt; Robert T Morris; William H Bradley; Matthew P Boente; Lari Wenzel Journal: Gynecol Oncol Date: 2018-05-18 Impact factor: 5.482
Authors: Jolyn S Taylor; Alaina J Brown; Lauren S Prescott; Charlotte C Sun; Lois M Ramondetta; Diane C Bodurka Journal: Gynecol Oncol Date: 2015-12-17 Impact factor: 5.482
Authors: Mali K Schneiter; Mohana B Karlekar; Marta A Crispens; Lauren S Prescott; Alaina J Brown Journal: Support Care Cancer Date: 2018-09-12 Impact factor: 3.603